ConductScience.org, home

Paper3000618

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

Wang D and 2 others. Cell, 1985. Cited by 1,129 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Papers, record 3000618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3000618

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
PubMed
Journal
Cell
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,129
iCite
Relative citation ratio, by iCite
23.7
iCite
Revised in PubMed
2019-07-05
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang DD
2Liebowitz DD
3Kieff EE

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, ViralMajor topic
Cell Transformation, ViralMajor topic
Herpesvirus 4, HumanMajor topic
Viral Matrix ProteinsMajor topic
Animals
Cell Division
Cell Line
Cloning, Molecular
Fibroblasts
Lymphocytes
Mice
Mice, Nude
Neoplasm Transplantation
Neoplasms, Experimental
Rats

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 17281NCI NIH HHSUnited StatesR01CA017281PubMed and NIHNIH RePORTER
CA 19264NCI NIH HHSUnited StatesP01CA019264PubMed and NIHNIH RePORTER
GM 07281NIGMS NIH HHSUnited StatesT32GM007281PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by457

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,129 citations.

PMIDTitleJournalYearIn PapersSource
42075858Resveratrol Induces Proteasomal Degradation of PTPN1 to Enhance Cisplatin Sensitivity in Epstein-Barr Virus-Associated Malignancies.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42075858PubMed
41959378CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.bioRxiv2026https://conductscience.org/library/papers/41959378PubMed
41890102A CRISPR-Cas9 screen Reveals STEEP1 as a Key Host Dependency Factor for Epstein-Barr Virus Latent Membrane Protein 1 Trafficking and Signaling.bioRxiv2026https://conductscience.org/library/papers/41890102PubMed
41587214Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway.PLoS Pathog2026https://conductscience.org/library/papers/41587214PubMed
41311374Epstein-Barr virus LMP1 promotes tumorigenesis in a murine epithelial tumor model.Biochem Biophys Rep2025https://conductscience.org/library/papers/41311374PubMed
40950096Epstein-Barr Virus Latent Membrane Protein 1 targets cIAP1, cIAP2 and TRAF2 for Proteasomal Degradation to Activate the Non-canonical NF-κB Pathway.bioRxiv2025https://conductscience.org/library/papers/40950096PubMed
40685972EBV Latency Programs: Molecular and Epigenetic Regulation and Its Role in Disease Pathogenesis.J Med Virol2025https://conductscience.org/library/papers/40685972PubMed
40573426The Use of Intrinsic Disorder and Phosphorylation by Oncogenic Viral Proteins to Dysregulate the Host Cell Cycle Through Interaction with pRb.Viruses2025https://conductscience.org/library/papers/40573426PubMed
40534857T cell-mediated immune surveillance conferred by latent Epstein-Barr virus genes suppresses a broad spectrum of tumor formation through NKG2D-NKG2DL interactions.Front Immunol2025https://conductscience.org/library/papers/40534857PubMed
40367275Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism.PLoS Pathog2025https://conductscience.org/library/papers/40367275PubMed
40047459Incorporation of Epstein-Barr viral variation implicates significance of Latent Membrane Protein 1 in survival prediction and prognostic subgrouping in Burkitt lymphoma.Int J Cancer2025https://conductscience.org/library/papers/40047459PubMed
39948602Detection of the 30-bp deletion and protein expression of Epstein-Barr virus latent membrane protein 1 in extranodal NK/T cell lymphoma and its clinicopathological significance.Diagn Pathol2025https://conductscience.org/library/papers/39948602PubMed
39843898Intrinsic p53 activation restricts gammaherpesvirus driven germinal center B cell expansion during latency establishment.Nat Commun2025https://conductscience.org/library/papers/39843898PubMed
395138553D-Q-FISH/Telomere/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin Lymphoma.Cells2024https://conductscience.org/library/papers/39513855PubMed
39001390Serum NF-κB in Epstein-Barr Virus-Related Oropharyngeal Carcinoma Diagnostic Usability.Cancers (Basel)2024https://conductscience.org/library/papers/39001390PubMed
38675906Deciphering the Role of Epstein-Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective.Viruses2024https://conductscience.org/library/papers/38675906PubMed
38195569Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex.Nat Commun2024https://conductscience.org/library/papers/38195569PubMed
38136637Role of Virus-Induced EGFR Trafficking in Proviral Functions.Biomolecules2023https://conductscience.org/library/papers/38136637PubMed
38004636Establishment of Epstein-Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1.Microorganisms2023https://conductscience.org/library/papers/38004636PubMed
37493769Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma.Braz J Med Biol Res2023https://conductscience.org/library/papers/37493769PubMed

See all 457 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PDLIM79260PubTator's text mininghttps://conductscience.org/library/genes/9260

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3000618

GET https://conductscience.org/api/papers/v1/3000618/cited_by?page=2